Management of Seizure During Labor
If eclampsia is suspected (no prior epilepsy history, hypertension, proteinuria), immediately administer magnesium sulfate as first-line treatment; if seizures persist or eclampsia is ruled out, treat with benzodiazepines followed by levetiracetam, fosphenytoin, or valproate as second-line agents.
Critical First Step: Determine the Etiology
The management algorithm hinges on distinguishing eclamptic from non-eclamptic seizures:
Eclampsia Indicators:
- Blood pressure ≥160/110 mmHg persisting >15 minutes 1
- Third trimester or immediate postpartum period
- No prior epilepsy history
- Associated symptoms: severe headache, visual changes, epigastric pain (though these may be absent) 2
Known Epilepsy Indicators:
- Documented seizure disorder (present in 69% of pregnant women with seizures in ED) 3
- Currently on antiseizure medications 3
Treatment Algorithm
For Suspected Eclampsia:
- Magnesium sulfate is the definitive first-line agent 4
- If seizures persist despite magnesium sulfate, add standard antiseizure medications (ASMs) - this approach achieved seizure control in 4 of 7 eclampsia cases 3
- Maintain blood pressure <160/110 mmHg with antihypertensive therapy 1
For Non-Eclamptic Seizures (Known Epilepsy or Eclampsia Ruled Out):
First-line: Benzodiazepines (lorazepam or midazolam) for immediate seizure cessation 4, 5
Second-line (if seizures continue after adequate benzodiazepine dosing): Choose one of the following - all have similar efficacy 6:
- Levetiracetam (safest cardiovascular profile: 0.7% hypotension, 0.7% arrhythmia, 20% intubation rate)
- Fosphenytoin (3.2% hypotension, 26.4% intubation rate)
- Valproate (1.6% hypotension, 16.8% intubation rate)
The ESETT trial demonstrated no significant difference in seizure cessation rates among these three agents (approximately 50% efficacy for each), but levetiracetam showed the most favorable safety profile 6.
Critical Peripartum Considerations
The peripartum period carries heightened seizure risk - 7.5% of women with epilepsy experience peripartum seizures (double the general labor rate of 3.5%) 7. This elevated risk extends up to 24 hours postpartum.
Common Pitfalls to Avoid:
Don't assume all peripartum seizures are eclamptic - 69% of pregnant women presenting with seizures have underlying epilepsy 3
Don't delay benzodiazepines in non-eclamptic cases - phenytoin or benzodiazepines are effective for seizure cessation during labor in epileptic patients 5
Don't withhold ASMs in eclampsia if magnesium sulfate fails - combination therapy is appropriate 3
Status epilepticus risk - occurs in 4.2% of cases and requires aggressive management 3
Medication Safety Notes
- Levetiracetam was the most commonly used ASM in recent pregnancy studies 3 and has the best safety profile for refractory seizures 6
- All three second-line agents (levetiracetam, fosphenytoin, valproate) can be used during labor with similar efficacy but different side effect profiles
- Neonatal vitamin K should be administered immediately after birth if phenytoin, phenobarbital, or carbamazepine were used 5
Post-Seizure Management
- Maintain seizure control throughout labor - proper control in the third trimester prevents intrapartum seizures 5
- Monitor for status epilepticus (continued convulsions beyond initial treatment)
- Assess for respiratory distress and altered consciousness (most frequent serious adverse events at 42%) 6
- Consider ICU-level monitoring given increased severe maternal morbidity risk in epileptic pregnancies 8